Literature DB >> 26891212

Effect of ischaemic preconditioning on recurrence of hepatocellular carcinoma in an experimental model of liver steatosis.

L A Orci1,2, S Lacotte1, G Oldani1,2, F Slits1, C De Vito2,3, L A Crowe4, L Rubbia-Brandt2,3, J-P Vallée4, P Morel1,2, C Toso1,2.   

Abstract

BACKGROUND: Livers with parenchymal abnormalities tolerate ischaemia-reperfusion (IR) injury poorly. IR injury is a risk factor for hepatocellular carcinoma (HCC) recurrence. This study assessed the link between liver parenchymal abnormalities and HCC recurrence, and evaluated the protective effect of ischaemic preconditioning.
METHODS: C57BL/6 mice were fed a choline-deficient diet for 6 and 12 weeks, or standard chow. Hepatic IR and ischaemic preconditioning were achieved by clamping liver blood inflow. Hepa 1-6 HCC cells were inoculated through the spleen. Thereafter, tumour burden, serum α-fetoprotein and cancer cell aggressiveness were compared among groups.
RESULTS: Hepatocellular damage and expression of inflammatory genes (encoding interleukin 6, tumour necrosis factor α, hypoxia inducible factor 1α and E-selectin) were exacerbated after IR injury in mice with severe steatosis. Compared with control livers or those with minimal steatosis, livers exposed to a prolonged choline-deficient diet developed larger tumour nodules and had higher serum α-fetoprotein levels. Non-ischaemic liver lobes from mice with steatosis were not protected from accelerated tumour growth mediated by IR injury. This remote effect was linked to promotion of the aggressiveness of HCC cells. Ischaemic preconditioning before IR injury reduced the tumour burden to the level of that in non-ischaemic steatotic controls. This protective effect was associated with decreased cancer cell motility.
CONCLUSION: Livers with steatosis tolerated IR poorly, contributing to more severe HCC recurrence patterns in mice with increasingly severe steatosis. IR injury also had a remote effect on cancer cell aggressiveness. Ischaemic preconditioning before IR injury reduced tumour load and serum α-fetoprotein levels. SURGICAL RELEVANCE: Liver ischaemia-reperfusion (IR) injury is associated with organ dysfunction and surgical morbidity. Livers with steatosis tolerate IR injury poorly in the setting of both liver resection and liver transplantation. Ischaemic preconditioning is a simple method to mitigate IR injury. This study shows that ischaemic preconditioning of mouse livers with steatosis reduces ischaemia-mediated tumour growth acceleration. Liver parenchymal abnormalities such as warm IR injury and liver steatosis should be taken into account to predict accurately the risk of liver cancer recurrence after surgical management. Ischaemic preconditioning strategies may hold therapeutic potential not only to mitigate surgical morbidity but also to reduce postoperative recurrence of liver cancer.
© 2016 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26891212     DOI: 10.1002/bjs.10080

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  [Clinical importance of perioperative organ protection : "Should" is closer to "must" than "can"…].

Authors:  Ulrich Göbel
Journal:  Anaesthesiologie       Date:  2022-09-30

Review 2.  One Shoot, Two Birds: Alleviating Inflammation Caused by Ischemia/Reperfusion Injury to Reduce the Recurrence of Hepatocellular Carcinoma.

Authors:  Hao Chen; Di Lu; Xinyu Yang; Zhihang Hu; Chiyu He; Huigang Li; Zuyuan Lin; Modan Yang; Xiao Xu
Journal:  Front Immunol       Date:  2022-05-11       Impact factor: 8.786

Review 3.  Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.

Authors:  Gonzalo Sapisochin; Jordi Bruix
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

4.  Shorter Survival after Liver Pedicle Clamping in Patients Undergoing Liver Resection for Hepatocellular Carcinoma Revealed by a Systematic Review and Meta-Analysis.

Authors:  Charles-Henri Wassmer; Beat Moeckli; Thierry Berney; Christian Toso; Lorenzo A Orci
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

5.  Pre-Transplant Alpha-Fetoprotein > 25.5 and Its Dynamic on Waitlist Are Predictors of HCC Recurrence after Liver Transplantation for Patients Meeting Milan Criteria.

Authors:  Bianca Magro; Domenico Pinelli; Massimo De Giorgio; Maria Grazia Lucà; Arianna Ghirardi; Alessandra Carrobio; Giuseppe Baronio; Luca Del Prete; Franck Nounamo; Andrea Gianatti; Michele Colledan; Stefano Fagiuoli
Journal:  Cancers (Basel)       Date:  2021-11-27       Impact factor: 6.639

Review 6.  Mitochondria and Cancer Recurrence after Liver Transplantation-What Is the Benefit of Machine Perfusion?

Authors:  Alessandro Parente; Mauricio Flores Carvalho; Janina Eden; Philipp Dutkowski; Andrea Schlegel
Journal:  Int J Mol Sci       Date:  2022-08-28       Impact factor: 6.208

7.  Ischemia-reperfusion injury and the risk of hepatocellular carcinoma recurrence after deceased donor liver transplantation.

Authors:  Michał Grąt; Marek Krawczyk; Karolina M Wronka; Jan Stypułkowski; Zbigniew Lewandowski; Michał Wasilewicz; Piotr Krawczyk; Karolina Grąt; Waldemar Patkowski; Krzysztof Zieniewicz
Journal:  Sci Rep       Date:  2018-06-12       Impact factor: 4.379

Review 8.  Impact of direct-acting antiviral agents on the development of hepatocellular carcinoma: evidence and pathophysiological issues.

Authors:  Maria Tampaki; Spiros Savvanis; John Koskinas
Journal:  Ann Gastroenterol       Date:  2018-09-14

9.  Ischemia reperfusion injury promotes recurrence of hepatocellular carcinoma in fatty liver via ALOX12-12HETE-GPR31 signaling axis.

Authors:  Faji Yang; Yuheng Zhang; Haozhen Ren; Jinglin Wang; Longcheng Shang; Yang Liu; Wei Zhu; Xiaolei Shi
Journal:  J Exp Clin Cancer Res       Date:  2019-12-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.